It was reported that a patient underwent a isvt ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac arrest, ventricular tachycardia (vt) and ventricular fibrillation (vf) and ultimately passed away.It was reported that after a vt case had completed, it was noticed that the patient went into cardiac arrest, and expired.They reported that the patient went into vt and then vf a few times during the procedure, which the anesthesiologist noticed on the anesthesia monitor.Patient was then "shocked" out of it and stable paced rhythm was restored.The procedure was then called and completed.After the catheters were removed from the body, and they were closing the groin, the anesthesiologist then noticed on the anesthesia monitor that the patient had gone into vt again.They performed acls protocol.The patient was coded for about 20-25 minutes, before they called it and the patient expired.The following bwi devices were also in use: webster® quadrapolar deflectable catheter (catheter information unknown) striker reprocessed acunav catheter (catheter information unknown) the date of death was (b)(6) 2023.Devices not available for return.All deaths were bwi fda approved ¿ ce mark devices are involved are reportable.
|
The device has been reported as discarded, therefore no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturer record evaluation cannot be conducted because the no lot number was provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|